<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2000/svg"><channel><title>Clinical Trials on Silicon Polder</title><link>https://hugo.bytes.news/tags/clinical-trials/</link><description>Recent content in Clinical Trials on Silicon Polder</description><generator>Hugo -- gohugo.io</generator><language>en</language><lastBuildDate>Thu, 12 Feb 2026 13:26:55 +0000</lastBuildDate><atom:link href="https://hugo.bytes.news/tags/clinical-trials/index.xml" rel="self" type="application/rss+xml"/><item><title>VectorY Therapeutics Integrates AI Digital Twins to Accelerate ALS Clinical Trial</title><link>https://hugo.bytes.news/posts/thursday/cb191e0-clinical-trials-artificial-intelligence/</link><pubDate>Thu, 12 Feb 2026 13:26:55 +0000</pubDate><guid>https://hugo.bytes.news/posts/thursday/cb191e0-clinical-trials-artificial-intelligence/</guid><description>&lt;p>&lt;em>Amsterdam, Thursday 12 February 2026&lt;/em>
VectorY collaborates with Unlearn to utilise AI-generated digital twins, creating prognostic patient forecasts to strengthen trial evidence and accelerate the development of their novel ALS genetic therapy.&lt;/p></description></item></channel></rss>